The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis

IntroductionEpstein−Barr virus (EBV) contributes significantly to the development and occurrence of B-cell lymphomas. However, the association between EBV infection status and clinical outcomes in Hodgkin lymphoma (HL) patients has long been controversial. Therefore, we aimed to estimate the prognos...

Full description

Bibliographic Details
Main Authors: Jianyu Hu, Xue Zhang, Huan Tao, Yongqian Jia
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1034398/full
_version_ 1811198318536032256
author Jianyu Hu
Xue Zhang
Huan Tao
Yongqian Jia
author_facet Jianyu Hu
Xue Zhang
Huan Tao
Yongqian Jia
author_sort Jianyu Hu
collection DOAJ
description IntroductionEpstein−Barr virus (EBV) contributes significantly to the development and occurrence of B-cell lymphomas. However, the association between EBV infection status and clinical outcomes in Hodgkin lymphoma (HL) patients has long been controversial. Therefore, we aimed to estimate the prognostic significance of EBV infection in HL survival.MethodsWe searched PubMed, Embase, Web of Science, and the Cochrane Library for relevant cohort studies from the date of their inception to February 20, 2022. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall survival (OS), Failure-free survival (FFS), Progression-free survival (PFS), Event-free survival (EFS) and disease-specific survival (DSS) were extracted from the studies or calculated. Subgroup analyses were conducted independently on the five survival outcomes to investigate the source of heterogeneity.ResultsA total of 42 qualified studies involving 9570 patients were identified in our meta-analysis. There was an association between EBV positivity and significantly poorer OS (HR=1.443, 95% CI: 1.250-1.666) and DSS (HR=2.312, 95% CI: 1.799-2.972). However, the presence of EBV in HL showed no effect on FFS, PFS or EFS. In subgroup analyses of OS, DSS and FFS stratified by age groups, EBV positivity was associated with poorer prognosis in elderly patients. Meanwhile, in children and adolescents with EBV-positive HL, we also observed a trend toward a better prognosis, though the results were not statistically significant.ConclusionsEBV-positive status is associated with poor OS and DSS in HL patients. EBV infection should therefore be considered a valuable prognostic marker and risk-stratifying factor in HL, especially in older patients.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022328708.
first_indexed 2024-04-12T01:28:19Z
format Article
id doaj.art-35c3e476fd834dfcb21b64af4f15f646
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T01:28:19Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-35c3e476fd834dfcb21b64af4f15f6462022-12-22T03:53:33ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.10343981034398The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysisJianyu HuXue ZhangHuan TaoYongqian JiaIntroductionEpstein−Barr virus (EBV) contributes significantly to the development and occurrence of B-cell lymphomas. However, the association between EBV infection status and clinical outcomes in Hodgkin lymphoma (HL) patients has long been controversial. Therefore, we aimed to estimate the prognostic significance of EBV infection in HL survival.MethodsWe searched PubMed, Embase, Web of Science, and the Cochrane Library for relevant cohort studies from the date of their inception to February 20, 2022. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall survival (OS), Failure-free survival (FFS), Progression-free survival (PFS), Event-free survival (EFS) and disease-specific survival (DSS) were extracted from the studies or calculated. Subgroup analyses were conducted independently on the five survival outcomes to investigate the source of heterogeneity.ResultsA total of 42 qualified studies involving 9570 patients were identified in our meta-analysis. There was an association between EBV positivity and significantly poorer OS (HR=1.443, 95% CI: 1.250-1.666) and DSS (HR=2.312, 95% CI: 1.799-2.972). However, the presence of EBV in HL showed no effect on FFS, PFS or EFS. In subgroup analyses of OS, DSS and FFS stratified by age groups, EBV positivity was associated with poorer prognosis in elderly patients. Meanwhile, in children and adolescents with EBV-positive HL, we also observed a trend toward a better prognosis, though the results were not statistically significant.ConclusionsEBV-positive status is associated with poor OS and DSS in HL patients. EBV infection should therefore be considered a valuable prognostic marker and risk-stratifying factor in HL, especially in older patients.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022328708.https://www.frontiersin.org/articles/10.3389/fonc.2022.1034398/fullEpstein – Barr virusHodking's lymphomaMeta - analysisprognosisVirus infection
spellingShingle Jianyu Hu
Xue Zhang
Huan Tao
Yongqian Jia
The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
Frontiers in Oncology
Epstein – Barr virus
Hodking's lymphoma
Meta - analysis
prognosis
Virus infection
title The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
title_full The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
title_fullStr The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
title_full_unstemmed The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
title_short The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
title_sort prognostic value of epstein barr virus infection in hodgkin lymphoma a systematic review and meta analysis
topic Epstein – Barr virus
Hodking's lymphoma
Meta - analysis
prognosis
Virus infection
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1034398/full
work_keys_str_mv AT jianyuhu theprognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT xuezhang theprognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT huantao theprognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT yongqianjia theprognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT jianyuhu prognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT xuezhang prognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT huantao prognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis
AT yongqianjia prognosticvalueofepsteinbarrvirusinfectioninhodgkinlymphomaasystematicreviewandmetaanalysis